Catalog No.
PHD43901
Species reactivity
Human
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human PDC (Met1-Glu246).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000
Target
Phosducin, PHD, 33 kDa phototransducing protein, Protein MEKA, PDC
Purification
Purified by antigen affinity column.
Accession
P20941
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Broadly reactive monoclonal antibodies against beta-lactamases for immunodetection of bacterial resistance to antibiotics., PMID:40447764
Tildrakizumab Treatment Patterns in Adults With Moderate-to-Severe Plaque Psoriasis: A Retrospective Analysis From the Canadian Patient Support Program., PMID:40442565
Immunogenic Properties of a Novel Hepatitis A Vaccine Candidate Based on a Fast-Growing Viral Strain., PMID:40432058
Peptide-Drug Conjugates as Next-Generation Therapeutics: Exploring the Potential and Clinical Progress., PMID:40428099
Effective cellular and neutralizing immunity against SARS-CoV-2 after mRNA booster vaccination is associated with pDC and B cell activation., PMID:40421016
Adherence and persistence among patients with hereditary angioedema receiving long-term prophylaxis in the United States., PMID:40300843
Current progress and remaining challenges of peptide-drug conjugates (PDCs): next generation of antibody-drug conjugates (ADCs)?, PMID:40259322
Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm., PMID:40141368
Evaluation of Dendritic Cell Subpopulations Frequency in COVID-19 Patients and their Correlation with Disease Severity., PMID:40130356
Sequential activation of conventional and plasmacytoid dendritic cells in autoimmune pancreatitis and systemic lupus erythematosus: similarities and dissimilarities., PMID:40040712
Innovative design concepts in tumor-targeting peptide-drug conjugates: Insights into emerging applications., PMID:40033748
Microbial Transglutaminase-The Food Additive, a Potential Inducing Factor in Primary Biliary Cholangitis., PMID:40005074
Distinct metabolic profiles of circulating plasmacytoid dendritic cells in systemic sclerosis patients stratified by clinical phenotypes., PMID:39972361
One-Year Compliance After Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy for Migraine Patients in a Real-World Setting: A Multicenter Cross-Sectional Study., PMID:39941406
The potential of lazertinib and amivantamab combination therapy as a treatment strategy for uncommon EGFR-mutated NSCLC., PMID:39874964
Antibodies directed against bacterial antigens in sera of Polish patients with primary biliary cholangitis., PMID:39844835
Novel Cyclic Peptide-Drug Conjugate P6-SN38 Toward Targeted Treatment of EGFR Overexpressed Non-Small Cell Lung Cancer., PMID:39771591
Development of a standardized monoclonal antibody to the inner lipoyl domain of PDC-E2 as a potential international AMA reference., PMID:39654533
Population-Based Study of the Epidemiology of Stiff Person Syndrome in a Large Colorado-Based Health System., PMID:39621949
Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy., PMID:39562279
Autoantibodies Against Dihydrolipoamide S-Acetyltransferase Are Not Associated With Immune-Mediated Neuropathies., PMID:39556782
Safety, tolerability, and immunogenicity of PIKA-adjuvanted recombinant SARS-CoV-2 spike protein subunit vaccine in healthy adults: an open-label randomized phase I clinical trial., PMID:39525677
Cell damage shifts the microRNA content of small extracellular vesicles into a Toll-like receptor 7-activating cargo capable to propagate inflammation and immunity., PMID:39516877
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial., PMID:39486411
Identification of a novel PDC-E2 epitope in primary biliary cholangitis: Application for engineered Treg therapy., PMID:39476446
Mouse enteric neurons control intestinal plasmacytoid dendritic cell function via serotonin-HTR7 signaling., PMID:39455564
Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC., PMID:39448966
Real-world persistence and adherence of ofatumumab versus oral and injectable disease-modifying therapies in patients with multiple sclerosis., PMID:39388747
Real-world experience with biosimilar infliximab-adba and infliximab-dyyb among infliximab-naïve patients with inflammatory bowel disease in the Veterans Health Administration., PMID:39287304
A positive cytokine/chemokine feedback loop establishes plasmacytoid DC-driven autoimmune pancreatitis in IgG4-related disease., PMID:39264798
Changes in use of acute and preventive medications for migraine after erenumab initiation over 12 months: A United States retrospective cohort study., PMID:39248147
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial., PMID:39236736
Treatment Targets Should Influence Choice of Infliximab Dose Intensification Strategy in Inflammatory Bowel Disease: A Pharmacokinetic Simulation Study., PMID:39168947
Automated Immunoprecipitation, Sample Preparation, and Individual Ion Mass Spectrometry Platform for Proteoforms., PMID:39143757
Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF., PMID:39078728
LC-MS/MS method for dual-ligand peptide-drug CBP-1018 and its deconjugated payload MMAE including sample stabilization strategy for its MC-Val-Cit-PABC linker., PMID:39053362
Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial., PMID:39032928
Essential role of pre-existing humoral immunity in TLR9-mediated type I IFN response to recombinant AAV vectors in human whole blood., PMID:39007143
Lupus IgA1 autoantibodies synergize with IgG to enhance plasmacytoid dendritic cell responses to RNA-containing immune complexes., PMID:38959329
Neutralizing antibodies after nebulized phage therapy in cystic fibrosis patients., PMID:38917792
Role of plasmacytoid dendritic cells in vascular dysfunction in mice with renovascular hypertension., PMID:38882290
Siglec-H-/- Plasmacytoid Dendritic Cells Protect Against Acute Liver Injury by Suppressing IFN-γ/Th1 Response and Promoting IL-21+ CD4 T Cells., PMID:38849082
In vitro throughput screening of anticancer drugs using patient-derived cell lines cultured on vascularized three-dimensional stromal tissues., PMID:38801868
Improved Access to Potent Anticancer Tubulysins and Linker-Functionalized Payloads Via an All-On-Resin Strategy., PMID:38771268
Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria., PMID:38669354
Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice., PMID:38653165
Adherence, persistence and treatment switching in psoriasis., PMID:38651935
Exposing the molecular heterogeneity of glycosylated biotherapeutics., PMID:38627419
Integrin αvβ3 Limits Cytokine Production by Plasmacytoid Dendritic Cells and Restricts TLR-Driven Autoimmunity., PMID:38607278
The presence of CpGs in AAV gene therapy vectors induces a plasmacytoid dendritic cell-like population very early after administration., PMID:38520831
For research use only. Not for human or drug use.
